Edit |   |
---|---|
Antigenic Specificity | CD25 |
Clone | monoclonal |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | n/a |
Format | unconjugated |
Size | n/a |
Concentration | n/a |
Applications | ELISA, Neut, IF, IP, FC, FuncS, |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD25 Recombinant Antibody (Daclizumab). Recombinant monoclonal antibody to Human CD25. Daclizumab (trade name daclizumab) is a therapeutic humanized monoclonal antibody. It is used to prevent rejection in organ transplantation, especially in kidney transplants. The drug is also under investigation for the treatment of multiple sclerosis. Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T cells. |
Immunogen | The details of the immunogen for this antibody are not available. |
Other Names | Daclizumab;daclizumab;152923-56-3;dacliximab;Ro 24-7375;anti-TAC;DB00111IL2RA;interleukin 2 receptor, alpha;IL2R;interleukin-2 receptor subunit alpha;CD25;p55;IL2-RA;IL-2-RA;TAC antigen;IL-2R subunit alpha;IL-2 receptor subunit alpha;TCGFR;IDDM10; |
Gene, Accession # | UniProt: P01589 |
Catalog # | TAB-023 |
Price | please inquire |
Order / More Info | CD25 Antibody from CREATIVE BIOLABS, INC. |
Product Specific References | n/a |